Biosciences Division offering expanded services
Huntsville, Ala. — Trideum Corporation, a Huntsville solutions and services provider, is expanding its newly formed Biosciences division to HudsonAlpha. Trideum’s new division includes laboratory testing, developing custom biologicals and scientific consultation.
Founded in 2005 by president and CEO Van Sullivan, Trideum has an experienced staff of more than 100 professionals who are experts in modeling and simulation, operations research, system engineering, software engineering and technical integration.
In the company’s biosciences services division, Sullivan said, Trideum employs a uniquely tailored approach for providing scientific solutions to clients, such as cost-effective, high-quality, custom DNA for diagnostic assay development and validation.
“Our goal with coming to HudsonAlpha is to become integrated with the life sciences community in Huntsville and to build a local network with the experts at the institute,” said Sullivan.
Directing the biosciences team at Trideum is Mina Izadjoo, Ph.D. Dr. Izadjoo’s research has mostly focused on developing and evaluating novel diagnostics and therapeutics.
The Trideum Biosciences team has expertise in conducting various testing and evaluation studies including anti-biofilm efficacy testing; conducting antibody and cell-based assays, and extracting high quality genomic material from infectious agents. Additionally, Trideum offers scientific consultation and partnerships in scientific grant writing.
Trideum will continue the existing operations in laboratories in Maryland while expanding operations at HudsonAlpha.
“HudsonAlpha is pleased to see Trideum expand their biosciences group to the Institute. We look forward to seeing Trideum grow as a result of being a part of the HudsonAlpha collaborative environment,” said Carter Wells, Vice President for Economic Development at HudsonAlpha Institute for Biotechnology.
About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to innovating in the field of genomic technology and sciences across a spectrum of biological challenges. Founded in 2008, its mission is four-fold: sparking scientific discoveries that can impact human health and well-being; bringing genomic medicine into clinical care; fostering biotech entrepreneurship; and encouraging the creation of a genomics-literate workforce and society. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation’s second largest research park. Designed to be a hothouse of biotech economic development, HudsonAlpha’s state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. The relationships formed on the HudsonAlpha campus encourage collaborations that produce advances in medicine and agriculture. Under the leadership of Dr. Richard M. Myers, a key collaborator on the Human Genome Project, HudsonAlpha has become a national and international leader in genetics and genomics research and biotech education, and includes 29 diverse biotech companies on campus. To learn more about HudsonAlpha, visit: http://hudsonalpha.org/.
